Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
gptkb:monoclonal_antibody |
| gptkbp:ATCCode |
none
|
| gptkbp:CASNumber |
1610353-18-0
|
| gptkbp:developedBy |
gptkb:XBiotech
gptkb:atopic_dermatitis inflammatory diseases hidradenitis suppurativa |
| https://www.w3.org/2000/01/rdf-schema#label |
Bermekimab
|
| gptkbp:legalStatus |
investigational
|
| gptkbp:macromoleculeType |
gptkb:IgG1_kappa
|
| gptkbp:mechanismOfAction |
blocks interleukin-1 alpha activity
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:target |
interleukin-1 alpha
|
| gptkbp:UNII |
6QY1D9Y4F2
|
| gptkbp:bfsParent |
gptkb:XBiotech
|
| gptkbp:bfsLayer |
6
|